Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener Medizinische Wochenschrift 15-16/2022

01.11.2022 | editorial

Multiple sclerosis at the crossroads of scientific evidence and clinical translation

verfasst von: FAAN FEAN FANA MBA Prof. Dr. Johann Sellner

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 15-16/2022

Einloggen, um Zugang zu erhalten
share
TEILEN

Excerpt

Few neurological conditions have witnessed such a magnitude of clinical and therapeutic advances over recent years as multiple sclerosis (MS). In addition, there is now a greater understanding of the underlying genetic and environmental factors involved in the condition’s pathogenesis. Indeed, the causality of Epstein–Barr virus infection and the development of MS has been corroborated only recently. Moreover, the relevance of comorbidities for the disease course and individual quality of life is now acknowledged. Currently, there are efforts to translate the improved understanding of MS-related comorbidities into clinical practice. …
Literatur
Metadaten
Titel
Multiple sclerosis at the crossroads of scientific evidence and clinical translation
verfasst von
FAAN FEAN FANA MBA Prof. Dr. Johann Sellner
Publikationsdatum
01.11.2022
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 15-16/2022
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-022-00936-z

Weitere Artikel der Ausgabe 15-16/2022

Wiener Medizinische Wochenschrift 15-16/2022 Zur Ausgabe